This study examined the relationship between early childhood risk factors for antisocial behavior and the monetary costs associated with criminal convictions for 379 clinic-referred boys. Participants were assessed using a structured risk assessment instrument, the Early Assessment Risk List for Boys (EARL-20B), intended for use with boys aged 6-11 with conduct problems. Criminal conviction data were used to calculate costs borne by victims, the correctional system, and other areas of the criminal justice system for participants between the ages of 12 and 20. For the total sample, the average cost per person was $580,181. Using the EARL-20B total score to derive quartile groups, the average lowest and highest risk quartile boys cost $361,581 and $878,460, respectively. Including estimates associated with undetected crimes increased per-person estimates to $1,058,854 and $3,536,441. For all risk groups, most of the costs occurred during mid-to-late adolescence, between the ages of 15-17. Analyses of individual EARL-20B items revealed that the three most expensive risk factors were manifesting antisocial attitudes ($920,657), poor coping ability ($768,416), and poor academic performance ($772,256). The results from this study show that it is possible to quantify childhood risk in monetary terms, and that substantial cost savings can be realized if developmental crime prevention programs are targeted at antisocial children before they reach the age of criminal liability. Psychologists play an important role in this pursuit by developing and using risk/needs assessment instruments, choosing and targeting interventions based on the results, developing new programs, training personnel, and evaluating the effectiveness of programs. (PsycInfo Database Record (c) 2021 APA, all rights reserved).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1037/ser0000401 | DOI Listing |
Scand J Prim Health Care
January 2025
Unit of Physiotherapy, Department of Health and Rehabilitation, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Research has shown that physical activity on prescription (PAP), used in Swedish healthcare, increases patients' physical activity, but data are lacking regarding the long-term effects of PAP on exercise capacity. Therefor exercise capacity was evaluated in patients with metabolic risk factors, after 4.5 years of PAP treatment provided by physiotherapists in primary healthcare.
View Article and Find Full Text PDFClin Exp Med
January 2025
Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, Poland.
Immune checkpoint inhibitors have improved the treatment of metastatic renal cell carcinoma (RCC), with the combination of nivolumab (NIVO) and ipilimumab (IPI) showing promising results. However, not all patients benefit from these therapies, emphasizing the need for reliable, easily assessable biomarkers. This multicenter study involved 116 advanced RCC patients treated with NIVO + IPI across nine oncology centers in Poland.
View Article and Find Full Text PDFSupport Care Cancer
January 2025
Department of Nursing, Nanfang Hosptial of Southern Medical University, Guangzhou, 510515, People's Republic of China.
Purpose: Our study aim was to understand the (human and organizational) factors influencing fall risk among people with hematological malignancies using the Reason model as a framework, providing insights that can inform the development of safe and effective fall management strategies.
Methods: Purposive sampling was employed to conduct semi-structured interviews with 13 people with hematological malignancies and 12 nurses from the hematology department of a tertiary grade A hospital in Guangzhou from December 2023 to February 2024. The topic analysis method was utilized to analyze the interview data.
AAPS J
January 2025
Department of BioAnalytical Sciences, Genentech Inc, South San Francisco, California, USA.
Protein-based therapeutics may elicit undesired immune responses in a subset of patients, leading to the production of anti-drug antibodies (ADA). In some cases, ADAs have been reported to affect the pharmacokinetics, efficacy and/or safety of the drug. Accurate prediction of the ADA response can help drug developers identify the immunogenicity risk of the drug candidates, thereby allowing them to make the necessary modifications to mitigate the immunogenicity.
View Article and Find Full Text PDFHeart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are increasingly prevalent cardiovascular conditions, particularly among the elderly population. These two conditions share common risk factors and often coexist, leading to a complex interplay that alters the clinical course of each other. The pathophysiology of HFpEF is multifaceted and intricately linked, with atrial disease serving as a common pathophysiological pathway.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!